GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Other Long Term Assets

Adimmune (TPE:4142) Other Long Term Assets : NT$1,065 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Adimmune Other Long Term Assets?

Adimmune's other long-term assets for the quarter that ended in Mar. 2025 was NT$1,065 Mil.

Adimmune's quarterly other long-term assets declined from Sep. 2024 (NT$1,215 Mil) to Dec. 2024 (NT$1,006 Mil) but then increased from Dec. 2024 (NT$1,006 Mil) to Mar. 2025 (NT$1,065 Mil).

Adimmune's annual other long-term assets increased from Dec. 2022 (NT$923 Mil) to Dec. 2023 (NT$1,102 Mil) but then declined from Dec. 2023 (NT$1,102 Mil) to Dec. 2024 (NT$1,006 Mil).

Adimmune Other Long Term Assets Historical Data

The historical data trend for Adimmune's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adimmune Other Long Term Assets Chart

Adimmune Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 935.63 650.26 922.79 1,101.97 1,005.94

Adimmune Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,212.21 1,128.03 1,215.27 1,005.94 1,064.73

Adimmune Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Adimmune Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Other Long Term Assets
Comparable Companies
ROCO:7759 TPE:6949 ROCO:4157 ROCO:6875 ROCO:6586 ROCO:4726 ROCO:4167 TPE:1760 ROCO:6976 TPE:1734 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Tanxing Road, No. 3, Sector 1, Tanzi District, Taichung, TWN, 427003
Website
https://www.adimmune.com.tw
Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.

Adimmune Headlines

No Headlines